FDA extends deadline for Philip Morris IQOS comments

The US Food and Drug Administration (FDA) has extended the deadline for comments on Philip Morris International’s (PMI’s) modified risk tobacco product application (MRTPA) for its IQOS heated tobacco device and Heatstick consumables. ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik